327 filings
Page 2 of 17
8-K
r22y1r21nfg
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
zb86sf
17 May 23
Letter to shareholders
4:00pm
PX14A6G
odm8p5x7mkzcrtu 6h
11 May 23
Letter to shareholders
11:34am
DEFA14A
xkyxf7hpz9a9
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
yh0sr2tor1t
5 May 23
Letter to shareholders
11:17am
8-K
2xtv92vaahaj
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
b89edyc 1pdmgid
3 May 23
Letter to shareholders
2:53pm
DEFA14A
5i24z 4r7e
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
900rrlng0rw
28 Apr 23
Additional proxy soliciting materials
4:03pm
PX14A6G
x97372x yosf036liy
26 Apr 23
Letter to shareholders
10:20am
8-K
fks8n7y3calt1
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
8-K
jydj14v2d891jqes
13 Mar 23
Other Events
6:03am
8-K
nsr 3zbg7asbsp4zh
28 Feb 23
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
6:03am
8-K
o1uwc a5a
27 Jan 23
Other Events
4:07pm
8-K
txf2j7760oc nhcc1ju
9 Jan 23
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results
4:10pm
8-K
r4cl3ym439
3 Jan 23
Other Events
4:34pm